CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -3.39M | -18.54M | -18.90M | 2.30M |
| Total Depreciation and Amortization | 427.80K | 368.40K | 449.40K | 461.70K | 460.10K |
| Total Amortization of Deferred Charges | 28.40K | 37.20K | 113.00K | 113.00K | 84.60K |
| Total Other Non-Cash Items | 1.95M | 2.19M | 17.01M | 17.18M | -4.83M |
| Change in Net Operating Assets | 99.10K | 315.40K | 632.70K | 813.70K | 1.79M |
| Cash from Operations | -590.70K | -479.20K | -332.40K | -335.50K | -197.40K |
| Capital Expenditure | -4.20K | -23.20K | -23.20K | -23.20K | -19.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | 0.00 | 259.50K | 189.50K | 139.50K | 130.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.60K | -106.40K | -106.40K | -106.40K | -71.70K |
| Cash from Investing | -56.80K | 129.90K | 59.90K | 9.90K | 39.80K |
| Total Debt Issued | 262.80K | 184.40K | 460.80K | 570.80K | 460.80K |
| Total Debt Repaid | 0.00 | 0.00 | -50.00K | -50.00K | -80.00K |
| Issuance of Common Stock | 406.30K | 406.30K | -- | -- | -- |
| Repurchase of Common Stock | -92.60K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 576.50K | 590.70K | 410.80K | 520.80K | 380.80K |
| Foreign Exchange rate Adjustments | 5.70K | -3.90K | -3.90K | -3.90K | -9.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.40K | 237.60K | 134.50K | 191.40K | 213.70K |